Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Poly Medicure manufactures medical devices and disposables under the Polymed brand — infusion therapy products such as IV cannulae and catheters, dialysis and renal care products, oncology, respiratory and surgery consumables. A large share of revenue comes from exports to Europe and other regulated/semi-regulated markets, complemented by a growing domestic hospital franchise. It is expanding into higher-value segments like dialysis machines and cardiology consumables.
It is among India's leading medical-consumables exporters and a global-scale maker of IV cannulae.
Poly Medicure Ltd. is a constituent of NIFTY 500, NIFTY SMALLCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Poly Medicure Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 31.79 | 34.13 | 26.92 |
| Book value / share (₹) | 310.70 | 272.95 | 153.18 |
| Return on equity | 10.2% | 12.2% | 17.6% |
| Return on capital employed | 9.8% | 13.1% | 19.5% |
| Operating margin | 17.4% | 22.2% | 21.4% |
| Net margin | 17.1% | 20.3% | 18.8% |
| EBITDA | ₹442 Cr | ₹453 Cr | ₹358 Cr |
| Free cash flow | ₹-68 Cr | ₹-84 Cr | ₹-11 Cr |
| Total debt | ₹342 Cr | ₹178 Cr | ₹170 Cr |
| Debt to equity | 0.11 | 0.06 | 0.12 |
| Interest coverage | 17.9 | 30.9 | 26.0 |
| Current ratio | 3.37 | 5.18 | 2.40 |
| Shares outstanding | 10,13,59,400 | 10,13,25,800 | 9,59,71,600 |
Open the full income statement, balance sheet and cash flow for POLYMED →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.